Cardiology

Risks, benefits of cangrelor consistent in angina, ACS

(HealthDay)—For patients with stable angina (SA) or acute coronary syndrome (ACS), the benefits and risks of cangrelor are consistent, according to a study published in the Sept. 26 issue of JACC: Cardiovascular Interventions.

Cardiology

Achieving optimal medical tx before PCI beneficial in CAD

(HealthDay)—In patients with coronary artery disease (CAD), achievement of optimal medical therapy (OMT) before implantation of a drug-eluting stent significantly reduces subsequent cardiac events, according to a study ...

Cardiology

Less efficacy than expected in largest drug-eluting stent trial

Rome, Italy 30 August 2016: New generation drug eluting stents (new DES) did not outshine contemporary bare metal stents (BMS) as they were expected to, in a surprise finding of the largest randomized stent trial to date.

Cardiology

Anemia independently linked to high platelet reactivity in PCI

(HealthDay)—Anemia is independently associated with high platelet reactivity (HPR) and is associated with all-cause mortality and major bleeding after percutaneous coronary intervention with drug-eluting stents, according ...

Cardiology

Deferred stenting shows no clinical benefit

Delayed or deferred stent implantation in patients experiencing the deadliest form of heart attack—ST-segment elevation myocardial infarction (STEMI)—failed to reduce death from any cause, hospitalization for heart failure, ...

Cardiology

Novel blood thinner found to be safe and effective in women

Percutaneous coronary intervention (PCI) is a staple of modern day medicine in which cardiologists place a stent in a blood vessel around the heart in order to restore blood flow in people with heart disease. Blood thinners ...

page 11 from 34